Fate of 3,3′-diindolylmethane in cultured MCF-7 human breast cancer cells

Chemical Research in Toxicology

Volumn 19, Issue 3, 2006, Pages 436-442

  Staub, Richard E ^a   Onisko, Bruce ^a,b   Bjeldanes, Leonard F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WESTERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (1H INDOL 3 YLMETHYL) 2 OXINDOLE; 3 [HYDROXY (1H INDOL 3 YL)METHYL] 1,3 DIHYDRO 2 OXINDOLE 3,3' DIINDOLYLMETHANE; 3 HYDROXY 3 (1H INDOL 3 YLMETHYL) 2 OXINDOLE 3,3' DIINDOLYLMETHANE; 3 INDOLEMETHANOL; 3,3' DIINDOLYLMETHANE; BIS(1H INDOL 3 YL)METHANOL (3 METHYLENEHYDROXY 3,3' DIINDOLYLMETHANE); CARBAZOLE DERIVATIVE; CYTOCHROME P450 1A2; CYTOCHROME P450 INHIBITOR; ENZYME INDUCING AGENT; INDOLE DERIVATIVE; INDOLE[3,2 B]CARBAZOLE; LUCIFERASE; QUERCETIN; SKATOLE; SULFATASE; SULFATE; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; BRASSICA; BREAST CANCER; CANCER CELL CULTURE; CANCER PREVENTION; CELL LEVEL; CELL NUCLEUS MEMBRANE; CELL STRAIN MCF 7; CHEMICAL REACTION KINETICS; CONJUGATE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOSOL; DRUG METABOLISM; DRUG UPTAKE; ENZYMATIC DEGRADATION; EPOXIDATION; ESTROGEN ACTIVITY; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OXIDATION; PASSIVE TRANSPORT; RADIOACTIVITY; REPORTER GENE;

ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CHEMISTRY, PHYSICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; FEMALE; GENES, REPORTER; GLUCURONIDASE; HUMANS; INDICATORS AND REAGENTS; INDOLES; LUCIFERASES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROPHOTOMETRY, ULTRAVIOLET; SULFATASES;

BRASSICA; MINK CELL FOCUS-FORMING VIRUS;

EID: 33645464056     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx050325z     Document Type: Article

References (36)

1. Bradfield, C. A., and Bjeldanes, L. F. (1987) Structure-activity relationships of dietary indoles: a proposed mechanism of action as modifiers of xenobiotic metabolism. J. Toxicol. Environ. Health 21, 311-323.
2. Grose, K. R., and Bjeldanes, L. F. (1992) Oligomerization of indole-3-carbinol in aqueous acid. Chem. Res. Toxicol. 5, 188-193.
3. Stresser, D. M., Williams, D. E., Griffin, D. A., and Bailey, G. S. (1995) Mechanisms of tumor modulation by indole-3-carbinol: disposition and excretion in male Fischer 344 rats. Drug Metab. Dispos. 23, 965-975.
4. Wattenberg, L. W., and Loub, W. D. (1978) Inhibition of polycyclic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res. 38, 1410-1413.
5. Chen, I., McDougal, A., Wang, F., and Safe, S. (1998) Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 19, 1631-1639.
6. Le, H. T., Schaldach, C. M., Firestone, G. L., and Bjeldanes, L. F. (2003) Plant-derived 3,3′-diindolylmethane is a strong androgen antagonist in human prostate cancer cells. J. Biol. Chem. 278, 21136-21145.
7. Riby, J. E., Chang, G. H. F., Firestone, G. L., and Bjeldanes, L. F. (2000) Ligand-independent activation of estrogen receptor function by 3,3′-diindolylmethane in human breast cancer cells. Biochem. Pharmacol. 60, 167-177.
8. Hong, C., Kim, H.-A., Firestone, G. L., and Bjeldanes, L. F. (2002) 3,3′-Diindolylmethane (DIM) induces a G1 cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21WAF1/CIP1 expression. Carcinogenesis 23, 1297-1305.
9. Leong H., Firestone G. L., and Bjeldanes L. F. (2001) Cytostatic effects of 3,3′-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-alpha expression. Carcinogenesis 22, 1809-1817.
10. Ge, X., Yannai, S., Rennert, G., Gruener, N., and Fares, F. A. (1996) 3,3-Diindolylmethane induces apoptosis in human cancer cells. Biochem. Biophys. Res. Commun. 228, 153-158.
11. Hong, C., Firestone, G. L., and Bjeldanes, L. F. (2002) Bcl-2 family-mediated apoptotic effects of 3,3′-diindolylmethane (DIM) in human breast cancer cells. Biochem. Pharmacol. 63, 1085-1097.
12. Shilling, A. D., Carlson, D. B., Katchamart, S., and Williams, D. E. (2001) 3,3′-Diindolylmethane, a major condensation product of indole-3-carbinol, is a potent estrogen in the rainbow trout. Toxicol. Appl. Pharmacol. 170, 191-200.
13. Stresser, D. M., Bjeldanes, L. F., Bailey, G. S., and Williams, D. E. (1995) The anticarcinogen 3,3′-diindolylmethane is an inhibitor of cytochrome P-450. J. Biochem. Toxicol. 10, 191-201.
14. Sepkovic, D. W., Bradlow, H. L., and Bell, M. (2001) Quantitative determination of 3,3′-diindolylmethane in urine of individuals receiving indole-3-carbinol. Nutr. Cancer 41, 57-63.
15. Staub, R. E., Feng, C., Onisko, B., Bailey, G. S., Firestone, G. L., and Bjeldanes, L. F. (2002) Fate of indole-3-carbinol in cultured human breast tumor cells. Chem. Res. Toxicol. 15, 101-109.
16. Leete, E., and Marion, L. (1953) The hydrogenolysis of 3-hydroxymethylindole and other indole derivatives with lithium aluminum hydride. Can. J. Chem. 31, 775-784.
17. Bangal, P. R., and Chakravorti, S. (2000) Spectroscopy and photophysics of 1-phenylisatin and oxindole. Opt. Mater. (Amsterdam) 15, 131-141.
18. Brock, T. G., Paine, R., III, and Peters-Golden, M. (1994) Localization of 5-lipoxygenase to the nucleus of unstimulated rat basophilic leukemia cells. J. Biol. Chem. 35, 22059-22066.
19. Bjeldanes L. F., Kim J. Y., Grose K. R., Bartholomew J. C., and Bradfield C. A. (1991) Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Natl. Acad. Sci. U.S.A. 88, 9543-9547.
20. Otake, Y., Nolan, A. L., Walle, K., and Walle, T. (2000) Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells. J. Steroid Biochem. Mol. Biol. 73, 265-270.
21. Lautraite, S., Musonda, A. C., Doehmer, J., Edwards, G. O., and Chipman, J. K. (2002) Flavonoids inhibit genetic toxicity produced by carcinogens in cells expressing CYP1A2 and CYP1A1. Mutagenesis 17, 45-53.
22. Chang T. K., Chen J., and Lee W. B. (2001) Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2. J. Pharmacol. Exp. Ther. 299, 874-882.
23. Skordos, K. W., Skiles, G. L., Laycock, J. D., Lanza, D. L., and Yost, G. S. (1998) Evidence supporting the formation of 2,3-epoxy-3-methylindoline: a reactive intermediate of the pneumotoxin 3-methyl-indole. Chem. Res. Toxicol. 11, 741-749.
24. Diaz, G. J., Skordos, K. W., Yost, G. S., and Squires, E. J. (1999) Identification of phase I metabolites of 3-methylindole produced by pig liver microsomes. Drug Metab. Dispos. 27, 1150-1156.
25. Smith, D. J., Skiles, G. L., Appleton, M. L., Carlson, J. R., and Yost, G. S. (1993) Identification of goat and mouse urinary metabolites of the pneumotoxin, 3-methylindole. Xenobiotica 23, 1025-1044.
26. Diaz, G. J., and Squires, E. J. (2003) Phase II in vitro metabolism of 3-methylindole metabolites in porcine liver. Xenobiotica 33, 485-498.
27. Baek, C., Hansen-Moller, J., Friis, C., Cornett, C., and Hansen, S. H. (1997) Identification of selected metabolites of skatole in plasma and urine from pigs. J. Agric. Food Chem. 45, 2332-2340.
28. Hammond, A. C., Carlson, J. R., and Willett, J. D. (1979) The metabolism and disposition of 3-methylindole in goats. Life Sci. 25, 1301-1306.
29. Skiles, G. L., Adams, J. D., Jr., and Yost, G. S. (1989) Isolation and identification of 3-hydroxy-3-methyloxindole, the major murine metabolite of 3-methylindole. Chem. Res. Toxicol. 2, 254-259.
30. 13C NMR study of the prototropic equilibria of 2-indolinone. J. Mol. Struct. 160, 319-325.
31. Clarke, R., van den Berg, H. W., and Murphy, R. F. (1990) Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17beta-estradiol. J. Natl. Cancer Inst. 82, 1702-1705.
32. Wiseman, H. (1994) Tamoxifen: new membrane-mediated mechanisms of action and therapeutic advances. Trends Pharmacol. Sci. 15, 83-89.
33. Zheng, J., and Ramirez, V. D. (2000) Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Br. J. Pharmacol. 130, 1115-1123.
34. Benabadji, S. H., Wen, R., Zheng, J., Dong, X., and Yuan, S. (2004) Anticarcinogenic and antioxidant activity of diindolylmethane derivatives. Acta Pharmacol. Sin. 25, 666-671.
35. Cardoso, C. M. P., Almeida, L. M., and Custodio, J. B. A. (2004) Protection of tamoxifen against oxidation of mitochondrial thiols and NAD(P)H underlying the permeability transition induced by prooxidants. Chem.-Biol Interact. 148, 149-161.
36. Custodio, J. B. A., Dinis, T. C. P., Almeida, L. M., and Madeira, V. M. C. (1994) Tamoxifen and hydroxytamoxifen as intramembranous inhibitors of lipid peroxidation. Evidence for peroxyl radical scavenging activity. Biochem. Pharmacol. 47, 1989-1998.